Esperion Therapeutics Inc. (ESPR) Soars 5.25%

Esperion Therapeutics Inc. (ESPR) Soars 5.25%

Esperion Therapeutics Inc. (ESPR) had a good day on the market for Friday November 22 as shares jumped 5.25% to close at $49.55. About 521,422 shares traded hands on 6,237 trades for the day, compared with an average daily volume of n/a shares out of a total float of 27.33 million. After opening the trading day at $47.30, shares of Esperion Therapeutics Inc. stayed within a range of $49.67 to $47.04.

With today’s gains, Esperion Therapeutics Inc. now has a market cap of $1.35 billion. Shares of Esperion Therapeutics Inc. have been trading within a range of $58.50 and $33.13 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

Esperion Therapeutics Inc. is based out of Ann Arbor, MI and has some 76 employees. Its CEO is Timothy M. Mayleben.

Share:
Scroll Up
error: Content is protected !!